LLSCX
Price
$28.02
Change
-$0.20 (-0.71%)
Updated
Sep 20 closing price
VMCPX
Price
$352.79
Change
-$0.65 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

LLSCX vs VMCPX

Header iconLLSCX vs VMCPX Comparison
Open Charts LLSCX vs VMCPXBanner chart's image
Longleaf Partners Small-Cap
Price$28.02
Change-$0.20 (-0.71%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index InstitutionalPlus
Price$352.79
Change-$0.65 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
LLSCX vs VMCPX Comparison Chart
Loading...
VS
LLSCX vs. VMCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LLSCX is a Buy and VMCPX is a Buy.

FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 172B vs. LLSCX (754M). VMCPX pays higher dividends than LLSCX: VMCPX (1.51) vs LLSCX (0.88). LLSCX was incepted earlier than VMCPX: LLSCX (36 years) vs VMCPX (14 years). LLSCX is a more actively managed with annual turnover of: 24.00 vs. VMCPX (13.00). LLSCX has a lower initial minimum investment than VMCPX: LLSCX (10000) vs VMCPX (100000000). VMCPX (25.17) and LLSCX (24.09) have marching annual gain over last year. VMCPX return over 5 years is better than : 56.93 vs. LLSCX (24.63).
LLSCXVMCPXLLSCX / VMCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence36 years14 years-
Gain YTD12.21512.59397%
Front LoadN/AN/A-
Min. Initial Investment100001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets754M172B0%
Annual Yield % from dividends0.881.5158%
Returns for 1 year24.0925.1796%
Returns for 3 years11.319.85115%
Returns for 5 years24.6356.9343%
Returns for 10 years-8.99128.75-7%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHR3.060.01
+0.33%
Archer Aviation
SBT4.64-0.02
-0.43%
Sterling Bancorp
EBAY62.75-0.47
-0.74%
eBay
CNXC63.38-0.79
-1.23%
Concentrix Corp
NRBO3.19-0.07
-2.15%
NeuroBo Pharmaceuticals